BridgeBio Oncology Stock Forecast - Double Exponential Smoothing
| BBOT Stock | 12.29 0.23 1.84% |
The Double Exponential Smoothing forecasted value of BridgeBio Oncology Therapeutics on the next trading day is expected to be 12.30 with a mean absolute deviation of 0.38 and the sum of the absolute errors of 22.71. BridgeBio Stock Forecast is based on your current time horizon.
At this time the rsi of BridgeBio Oncology's share price is below 20 suggesting that the stock is significantly oversold. The fundamental principle of the Relative Strength Index (RSI) is to quantify the velocity at which market participants are driving the price of a financial instrument upwards or downwards. Momentum 6
Sell Peaked
Oversold | Overbought |
EPS Estimate Current Year (2.23) | EPS Estimate Next Year (2.05) | Wall Street Target Price 24.2 |
Using BridgeBio Oncology hype-based prediction, you can estimate the value of BridgeBio Oncology Therapeutics from the perspective of BridgeBio Oncology response to recently generated media hype and the effects of current headlines on its competitors.
BridgeBio Oncology Hype to Price Pattern
Investor biases related to BridgeBio Oncology's public news can be used to forecast risks associated with an investment in BridgeBio. The trend in average sentiment can be used to explain how an investor holding BridgeBio can time the market purely based on public headlines and social activities around BridgeBio Oncology Therapeutics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Some investors profit by finding stocks that are overvalued or undervalued based on market sentiment. The correlation of BridgeBio Oncology's market sentiment to its price can help taders to make decisions based on the overall investors consensus about BridgeBio Oncology.
The Double Exponential Smoothing forecasted value of BridgeBio Oncology Therapeutics on the next trading day is expected to be 12.30 with a mean absolute deviation of 0.38 and the sum of the absolute errors of 22.71. BridgeBio Oncology after-hype prediction price | USD 12.34 |
There is no one specific way to measure market sentiment using hype analysis or a similar predictive technique. This prediction method should be used in combination with more fundamental and traditional techniques such as stock price forecasting, technical analysis, analysts consensus, earnings estimates, and various momentum models.
BridgeBio | Build AI portfolio with BridgeBio Stock |
BridgeBio Oncology Additional Predictive Modules
Most predictive techniques to examine BridgeBio price help traders to determine how to time the market. We provide a combination of tools to recognize potential entry and exit points for BridgeBio using various technical indicators. When you analyze BridgeBio charts, please remember that the event formation may indicate an entry point for a short seller, and look at other indicators across different periods to confirm that a breakdown or reversion is likely to occur.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
BridgeBio Oncology Double Exponential Smoothing Price Forecast For the 6th of January
Given 90 days horizon, the Double Exponential Smoothing forecasted value of BridgeBio Oncology Therapeutics on the next trading day is expected to be 12.30 with a mean absolute deviation of 0.38, mean absolute percentage error of 0.26, and the sum of the absolute errors of 22.71.Please note that although there have been many attempts to predict BridgeBio Stock prices using its time series forecasting, we generally do not recommend using it to place bets in the real market. The most commonly used models for forecasting predictions are the autoregressive models, which specify that BridgeBio Oncology's next future price depends linearly on its previous prices and some stochastic term (i.e., imperfectly predictable multiplier).
BridgeBio Oncology Stock Forecast Pattern
| Backtest BridgeBio Oncology | BridgeBio Oncology Price Prediction | Buy or Sell Advice |
BridgeBio Oncology Forecasted Value
In the context of forecasting BridgeBio Oncology's Stock value on the next trading day, we examine the predictive performance of the model to find good statistically significant boundaries of downside and upside scenarios. BridgeBio Oncology's downside and upside margins for the forecasting period are 8.32 and 16.27, respectively. We have considered BridgeBio Oncology's daily market price to evaluate the above model's predictive performance. Remember, however, there is no scientific proof or empirical evidence that traditional linear or nonlinear forecasting models outperform artificial intelligence and frequency domain models to provide accurate forecasts consistently.
Model Predictive Factors
The below table displays some essential indicators generated by the model showing the Double Exponential Smoothing forecasting method's relative quality and the estimations of the prediction error of BridgeBio Oncology stock data series using in forecasting. Note that when a statistical model is used to represent BridgeBio Oncology stock, the representation will rarely be exact; so some information will be lost using the model to explain the process. AIC estimates the relative amount of information lost by a given model: the less information a model loses, the higher its quality.| AIC | Akaike Information Criteria | Huge |
| Bias | Arithmetic mean of the errors | 0.0881 |
| MAD | Mean absolute deviation | 0.3849 |
| MAPE | Mean absolute percentage error | 0.0317 |
| SAE | Sum of the absolute errors | 22.7112 |
Predictive Modules for BridgeBio Oncology
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as BridgeBio Oncology. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Other Forecasting Options for BridgeBio Oncology
For every potential investor in BridgeBio, whether a beginner or expert, BridgeBio Oncology's price movement is the inherent factor that sparks whether it is viable to invest in it or hold it better. BridgeBio Stock price charts are filled with many 'noises.' These noises can hugely alter the decision one can make regarding investing in BridgeBio. Basic forecasting techniques help filter out the noise by identifying BridgeBio Oncology's price trends.BridgeBio Oncology Related Equities
One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with BridgeBio Oncology stock to make a market-neutral strategy. Peer analysis of BridgeBio Oncology could also be used in its relative valuation, which is a method of valuing BridgeBio Oncology by comparing valuation metrics with similar companies.
| Risk & Return | Correlation |
BridgeBio Oncology Technical and Predictive Analytics
The stock market is financially volatile. Despite the volatility, there exist limitless possibilities of gaining profits and building passive income portfolios. With the complexity of BridgeBio Oncology's price movements, a comprehensive understanding of forecasting methods that an investor can rely on to make the right move is invaluable. These methods predict trends that assist an investor in predicting the movement of BridgeBio Oncology's current price.| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
BridgeBio Oncology Market Strength Events
Market strength indicators help investors to evaluate how BridgeBio Oncology stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading BridgeBio Oncology shares will generate the highest return on investment. By undertsting and applying BridgeBio Oncology stock market strength indicators, traders can identify BridgeBio Oncology Therapeutics entry and exit signals to maximize returns.
BridgeBio Oncology Risk Indicators
The analysis of BridgeBio Oncology's basic risk indicators is one of the essential steps in accurately forecasting its future price. The process involves identifying the amount of risk involved in BridgeBio Oncology's investment and either accepting that risk or mitigating it. Along with some essential techniques for forecasting bridgebio stock prices, we also provide a set of basic risk indicators that can assist in the individual investment decision or help in hedging the risk of your existing portfolios.
| Mean Deviation | 2.87 | |||
| Semi Deviation | 2.95 | |||
| Standard Deviation | 3.92 | |||
| Variance | 15.34 | |||
| Downside Variance | 9.12 | |||
| Semi Variance | 8.7 | |||
| Expected Short fall | (3.43) |
Please note, the risk measures we provide can be used independently or collectively to perform a risk assessment. When comparing two potential investments, we recommend comparing similar equities with homogenous growth potential and valuation from related markets to determine which investment holds the most risk.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for BridgeBio Stock Analysis
When running BridgeBio Oncology's price analysis, check to measure BridgeBio Oncology's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BridgeBio Oncology is operating at the current time. Most of BridgeBio Oncology's value examination focuses on studying past and present price action to predict the probability of BridgeBio Oncology's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BridgeBio Oncology's price. Additionally, you may evaluate how the addition of BridgeBio Oncology to your portfolios can decrease your overall portfolio volatility.